Temmler Werke Holding GmbH

What Temmler Werke Holding GmbH does

Temmler Werke Holding GmbH operates under the trade name Aenova Group and is a German-domiciled, privately held Contract Development and Manufacturing Organization (CDMO) for the pharmaceutical and healthcare industry, headquartered in Starnberg-Percha, Germany. The company describes itself as a "worldwide leading" contract manufacturer and operates three interconnected service lines: Pharmaceutical Manufacturing (contract production of tablets, capsules, and other dosage forms), Development & Technology (formulation, analytical development, and technology transfer), and Animal Health (specialized veterinary pharmaceutical manufacturing). Additional capabilities include a Sterile Technologies Competence Center in Latina and an in-house global Pharmacovigilance function covering adverse reaction monitoring and regulatory reporting for medicinal products, medical devices, and cosmetics.

The business model is enterprise B2B contract manufacturing, with revenue generated through long-term, individually negotiated manufacturing contracts with pharmaceutical and healthcare customers reached via direct enterprise field sales. Pricing is not publicly disclosed. The company maintains a corporate website, social channels (LinkedIn, Instagram, Facebook), and a bi-monthly CDMO newsletter as top-of-funnel marketing infrastructure, and is governed by Managing Directors Jan Kengelbach and Dr. Peter Waller. In June 2026, the firm achieved an EcoVadis Silver Medal for ESG performance, and appointed a new Managing Director for its Latina sterile site, with the Aenova Annual Report 2025 having been published in 2025.

The source data does not disclose revenue, employee headcount at the operating level (the firmographic figure of 19 appears to reflect the holding entity rather than the group), ownership structure beyond management, or a historical M&A record, so scale claims rest on self-reported positioning rather than disclosed financial metrics.

Name

Temmler Werke Holding GmbH

Legal name

Aenova Holding GmbH

Website

https://temmler.eu

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Temmler Werke Holding GmbH, operating as Aenova Group, is a German privately held pharmaceutical CDMO offering contract manufacturing, development, animal health, and sterile technologies services to pharmaceutical and healthcare companies worldwide through long-term enterprise contracts.

Ownership category

akta.pro rank

Product category

Pharmaceutical Contract Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Drug Substance–Drug Product Integrated CDMO (HLAGABAG)

akta.pro secondary industries

Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO (HLAGABAB), Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK), Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI)

Keywords

• Pharmaceutical contract manufacturing
• Contract development services
• Sterile dosage manufacturing
• Animal health manufacturing
• Pharmaceutical formulation development

Headquarters

HQ city

Starnberg (Percha)

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Contract Manufacturing Services: CDMO services providing pharmaceutical development and manufacturing to pharmaceutical and healthcare companies. Revenue generated through long-term manufacturing contracts with pharmaceutical customers.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Temmler Werke Holding GmbH operates the Aenova Group, a global contract development and manufacturing organization (CDMO) for the pharmaceutical and healthcare industry. Its core offering covers pharmaceutical contract manufacturing of tablets, capsules, and sterile dosage forms, alongside pharmaceutical development and technology services (formulation, analytical development, technology transfer) and specialized animal health product manufacturing.

Product overview

Aenova Group is a worldwide leading Contract Development and Manufacturing Organization (CDMO) serving the pharmaceutical and healthcare industry. The company operates as a single unified platform offering three interconnected service lines: Pharmaceutical Manufacturing (core manufacturing of dosage forms), Development & Technology (formulation and analytical development services), and Animal Health (specialized veterinary products). Additional services include Pharmacovigilance monitoring and specialized Sterile Technologies capabilities at its Latina facility. The company provides end-to-end services from development through commercial manufacturing for its pharmaceutical clients.

Differentiator

Problem solved

Functional benefit

Products and services

• Pharmaceutical Manufacturing Comprehensive contract manufacturing services for pharmaceutical products including tablets, capsules, and other dosage forms for global pharmaceutical and healthcare companies.
• Development & Technology Pharmaceutical development services including product formulation, analytical development, and technology transfer for pharmaceutical contract manufacturing clients.
• Animal Health Specialized pharmaceutical products and contract manufacturing services for animal health and veterinary pharmaceutical applications.
• Pharmacovigilance Services Worldwide safety monitoring of pharmaceutical products including adverse reaction tracking, side effect monitoring, and regulatory reporting for medicinal products, medical devices, and cosmetics.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators1 record

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Lonza Group: Lonza is one of the world's largest CDMOs spanning small molecules, biologics, and cell & gene therapy manufacturing. It competes with Aenova for pharmaceutical contract manufacturing customers and is a broad incumbent in the same end-to-end CDMO category.
• Boehringer Ingelheim BioXcellence: BioXcellence is the CDMO arm of Boehringer Ingelheim offering contract biopharmaceutical and fill-finish manufacturing services. As a large incumbent with overlapping pharmaceutical contract manufacturing capabilities, it competes with Aenova for pharma outsourcing contracts.

Direct peers

• Fareva: Fareva is a privately held French-headquartered pharmaceutical contract manufacturer offering sterile, solid, and semi-solid dose manufacturing across multiple European sites — directly comparable to Aenova's integrated European CDMO footprint and service portfolio.
• Recipharm: Recipharm is a European-headquartered CDMO offering contract development and manufacturing of pharmaceutical formulations including solid, semi-solid, and sterile dosage forms — directly comparable to Aenova across pharma contract manufacturing.
• CordenPharma: CordenPharma is a CDMO providing API manufacturing and drug product services including solid dose and sterile injectable fill-finish — directly comparable to Aenova's integrated Drug Substance–Drug Product CDMO offering for pharma customers.
• Vetter Pharma: Vetter is a specialist CDMO focused on aseptic filling of injectable pharmaceuticals and lyophilization, directly comparable to Aenova's Sterile Technologies Competence Center in Latina and its sterile fill-finish service line.
• Catalent: Catalent is a leading global CDMO offering solid oral dose, sterile fill-finish, and development services to pharma companies — a directly comparable integrated pharmaceutical contract manufacturer to Aenova across the same dosage form categories.
• Siegfried Holding: Siegfried is a Swiss-headquartered CDMO specializing in solid oral dosage forms, sterile manufacturing, and APIs — directly comparable to Aenova's pharmaceutical manufacturing and Development & Technology service lines for European and global pharma customers.
• PCI Pharma Services: PCI Pharma Services is a global CDMO providing integrated pharmaceutical development, manufacturing, and packaging services including sterile fill-finish — directly comparable to Aenova's contract manufacturing and packaging capabilities.
• Almac Group: Almac is a global CDMO offering pharmaceutical development, analytical services, and commercial manufacturing of solid oral dose and sterile products — a directly comparable integrated CDMO serving pharma companies across similar dosage form categories as Aenova.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/aenovagroup
• LinkedInlinkedin.com/company/temmler-werke-holding-gmbh
• Instagraminstagram.com/aenova_group

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Temmler Werke Holding GmbH